Sickle Cell Awareness Month

Sickle Cell Awareness Month is observed throughout September to raise understanding of sickle cell disease, a group of inherited blood disorders that affects red blood cells and can cause anemia, pain, fatigue, and other health complications. The month encourages people to learn about the condition, recognize the experiences of those living with it, and promote compassion and informed support.

Throughout September, communities, healthcare organizations, advocates, and families help share accurate information about prevention, treatment, and the importance of ongoing medical care. The observance also highlights advances in research and the need for greater awareness, equitable healthcare, and continued support for individuals and families affected by sickle cell disease.

Sickle Cell Awareness Month is observed throughout September to increase public understanding of sickle cell disease, a group of inherited blood disorders that affects hemoglobin and can cause anemia, severe pain, organ damage, and other complications. The observance emerged from decades of advocacy by patients, families, physicians, researchers, and community organizations seeking greater recognition of a condition that has historically received fewer resources and less public attention than many other serious diseases.

The medical history behind the observance reaches back to 1910, when physician James B. Herrick and colleagues published one of the first descriptions of the distinctive sickle-shaped red blood cells seen in a patient from Grenada. Researchers later established that the condition was inherited and identified the underlying hemoglobin alteration. In 1949, Linus Pauling and his collaborators demonstrated that sickle cell disease was a “molecular disease,” helping establish the field of molecular medicine. These discoveries eventually contributed to improved diagnosis, newborn screening, preventive care, and treatments such as hydroxyurea and blood transfusion therapies.

In the United States, federal recognition of a September awareness observance developed during the growth of sickle cell advocacy in the twentieth century. Patient-led groups and organizations such as the National Association for Sickle Cell Disease pressed for expanded research, comprehensive care, education, and equitable access to treatment. President Ronald Reagan formally proclaimed September as National Sickle Cell Anemia Awareness Month in 1983. Over time, the language used in public health efforts increasingly favored “sickle cell disease,” reflecting the range of related conditions and the importance of using terminology preferred by patients and medical organizations.

Today, Sickle Cell Awareness Month serves both an educational and cultural purpose. Throughout September, health institutions, advocacy groups, schools, and community organizations share information about symptoms, genetic inheritance, screening, treatment, clinical research, and the lived experiences of people with the disease. The observance also highlights racial and health-equity issues: sickle cell disease occurs most commonly among people with African, Mediterranean, Middle Eastern, and South Asian ancestry, while many patients continue to face stigma, undertreatment of pain, and barriers to specialized care. By centering patient voices and encouraging blood donation, research participation, and informed medical support, the month connects the history of sickle cell advocacy with continuing efforts to improve survival and quality of life.